EMD 281014, a new selective serotonin 5-HT2A receptor antagonist

被引:34
作者
Bartoszyk, GD [1 ]
van Amsterdam, C [1 ]
Böttcher, H [1 ]
Seyfried, CA [1 ]
机构
[1] Preclin Res Merck KGaA, Dept CNS Res, D-64271 Darmstadt, Germany
关键词
5-HT2A receptor antagonist; EMD; 281014; M; 100907;
D O I
10.1016/S0014-2999(03)01992-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The 5-HT2A receptor ligand 7-{4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-l-carbony}-1H-indole-3-carbonitrile HCl (EMD 281014) selectively binds to human (h) and rat 5-HT2A receptors (IC50 values 0.35 and 1 nM, respectively; vs. 1334 nM for h5-HT2C) and inhibited 5-HT-stimulated [S-35]guanosine 5'-O-3-thiotriphosphate (GTP-gammaS)-accumulation in h5-HT2A transfected Chinese hamster ovary cells (IC50 9.3 nM). EMD 281014 counteracted the N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-induced decrease of [H-3]ketanserin binding in rat frontal cortex (ID50 0.4 mg/kg p.o.) and R-(-)-1-(2,5-dimethoxy-4-iodophenyl)-aminopropane (DOI)-induced head-twitch behaviour in mice (ID50 0.01 mg/kg s.c., 0.06 mg/kg p.o.), demonstrating unique selectivity and efficacy. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 230
页数:2
相关论文
共 9 条
  • [1] THE PHARMACOLOGY AND DISTRIBUTION OF HUMAN 5-HYDROXYTRYPTAMINE(2B) (5-HT2B) RECEPTOR GENE-PRODUCTS - COMPARISON WITH 5-HT2A AND 5-HT2C RECEPTORS
    BONHAUS, DW
    BACH, C
    DESOUZA, A
    SALAZAR, FHR
    MATSUOKA, BD
    ZUPPAN, P
    CHAN, HW
    EGLEN, RM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (04) : 622 - 628
  • [2] TEMPORAL DIFFERENTIAL ADAPTATION OF HEAD-TWITCH AND EAR-SCRATCH RESPONSES FOLLOWING ADMINISTRATION OF CHALLENGE DOSES OF DOI
    DARMANI, NA
    GERDES, CF
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 50 (04) : 545 - 550
  • [3] de Angelis Luisa, 2002, Curr Opin Investig Drugs, V3, P106
  • [4] Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT2C/2B receptor antagonists:: neurochemical and behavioural studies
    Hutson, PH
    Barton, CL
    Jay, M
    Blurton, P
    Burkamp, F
    Clarkson, R
    Bristow, LJ
    [J]. NEUROPHARMACOLOGY, 2000, 39 (12) : 2318 - 2328
  • [5] Kehne JH, 1996, J PHARMACOL EXP THER, V277, P968
  • [6] The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex
    Kettle, CJ
    Cheetham, SC
    Martin, KF
    Prow, MR
    Heal, DJ
    [J]. NEUROPHARMACOLOGY, 1999, 38 (09) : 1421 - 1430
  • [7] KLOCKOW M, 1986, ARZNEIMITTEL-FORSCH, V36-1, P197
  • [8] Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635
    NewmanTancredi, A
    Conte, C
    Chaput, C
    Spedding, M
    Millan, MJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (05) : 737 - 739
  • [9] OFFORD S, 1998, CINP P, P377